Conference abstractPublished 29 Nov 2011
Exploring novel pathways of cell reprogramming and transdifferentiation for targeted stem cell therapies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Embryonic stem (ES) cells have become a major focus of scientifi c interest as a potential source for both, transplantable cells in regenerative medicine, and disease modeling. Human induced pluripotent stem (iPS) cells would represent an appealing option for the use of ES- like patient-specifi c cells as no embryos or oocytes are required for their derivation. However, crucial safety issues have to be addressed in order to create human iPS cells that are clinically useful as the classical iPS technique involves permanent genetic manipulation that may result in tumor formation. Our research focuses on the derivation of safe iPS cells, targeted diff erentiation into transplantable neural precursors and its application for disease modeling. In contrast to conventional gene transfer strategies the direct introduction of proteins and synthetic mRNA into cells bypasses the risk of insertional mutagenesis and thus off ers an alternative to genetic intervention. We show that protein transduction is a powerful approach to deliver biologically active proteins directly into cells. Th is paper presents the use of biologically active cell- permeant reprogramming factors to i) induce pluripotency in somatic cells and ii) study the molecular mechanism of reprogramming. Th us far, viral transduction of transcription factors still represents the preferred, most robust reprogramming system. We performed effi cient reprogramming transgene removal by cell-permeant recombinases to genetically clean such virally transduced human iPS cells. Finally, novel strategies will be presented for the targeted diff erentiation into neural lineages employing small molecules and instructive factors
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Frank Edenhofer”

